- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07771569
Simulation-based Training in the Anaesthesia Residency Curriculum
Study Overview
Status
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Tereza Prokopová, MD,PhD.
- Phone Number: +420736669784
- Email: prokopova.tereza@gmail.com
Study Contact Backup
- Name: Jan Hudec, MD, Ph.D.
- Phone Number: +420722944525
- Email: hudec.jan@fnbrno.cz
Study Locations
-
-
Česká Republika
-
Brno, Česká Republika, Czechia, 62500
- Masaryk University
-
Contact:
- Tereza Prokopová
- Phone Number: 736669784
- Email: prokopova.tereza@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- WFSA representatives.
Exclusion Criteria:
- not WFSA representatives.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Representatives of their countries in WFSA
|
|
Representatives of regional sections
|
|
Representatives of corresponding members
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
How many countries affiliated with WFSA have some type of simulation training included in the postgraduate curriculum?
Time Frame: 3 months
|
Number of WFSA-affiliated countries with obligatory training or optional training.
|
3 months
|
|
How many countries affiliated with WFSA have obligatory simulation training in Anaesthesia and Intensive Care?
Time Frame: 3 months
|
Prevalence of obligatory simulation training in postgraduate training in Anaesthesia and Intensive Care.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
What is required of the HCP to be able to provide anaesthesia unsupervised worldwide?
Time Frame: 3 months
|
Prevalence of answers about what is required of HCPs to provide unsupervised anaesthesia. The options are predefined; if these do not fit, participants could choose the "other" option and specify it as an open question. |
3 months
|
|
How extensive is the simulation training in Anaesthesiology and Intensive Care in countries affiliated with WFSA?
Time Frame: 3 months
|
The number of days of simulation training is obligatory or advisable during postgraduate training in Anaesthesia and Intensive Care.
Also, the frequency of subsequent training components.
|
3 months
|
|
Specification of simulation training
Time Frame: 3 months
|
The prevalence of simulation modalities (low-fidelity simulation, high-fidelity simulation, etc.) across WFSA-affiliated countries. The options are predefined, or if these do not fit, participants could choose "other" and specify in an open question. The prevalence of themes covered by simulation training. |
3 months
|
|
What are the major barriers limiting the wider implementation of simulation-based education in anaesthesia residency training in countries affiliated with WFSA?
Time Frame: 3 months
|
The prevalence of major barriers.
The participants will choose from predefined options; if these do not fit, they can select the "other" option and specify it in an open question.
|
3 months
|
|
What role do artificial intelligence and virtual reality play in simulation training?
Time Frame: 3 months
|
The prevalence of answers given on the theme of AI and VR.
|
3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Petr Štourač, prof., MD.,Ph.D., FESAIC, Department of Simulation Medicine, Faculty of Medicine, Masaryk University, Brno, Czech Republic
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SBET-AIM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.